| In the testing phase of antibiotic development, it is common to utilise piperacillin/tazobactam (TZP) to treat a wide range
of infections. It's safe, according to most people. Treatment with TZP may cause neutropenia, an uncommon but dangerous
side effect. The case of ceftriaxone neutropenia in an elderly patient is given in this paper based on clinical data and blood
tests. The patient's leucocyte and neutrophil counts began to decline on the third day of taking the medicine and continued
to decline on the fifth day. TZP has the possibility to trigger neutropenia in as little as 10 days, according to our research.
In order to further understand the link between TZP treatment and neutropenia, more study is requiredddd |
